Skip to main content
. 2019 Mar 20;2019:9682495. doi: 10.1155/2019/9682495

Figure 3.

Figure 3

The mean plasma concentration–time profiles of embelin after oral (a) and intravenous (b) administration (n = 6, mean ± SD).